Back to Trades
Koenig Sheldon L.
President and CEODirectorCIK 0001766524
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 4
- Buy transactions
- 0
- Sell transactions
- 2
- Companies
- 1
- Active
- 2025–2026
Across 4 filings between 2025–2026, Koenig Sheldon L., President and CEO, Director, has disclosed $1.9M in transactions — all concentrated in Esperion Therapeutics, Inc. (ESPR). Their disclosed trades are heavily weighted toward selling — $0 in buys and $346.3K in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
4 loaded
| Jul 13 | ESPR Esperion Therapeutics, Inc. | Koenig Sheldon L. | President and CEO, Director | Disposed | $0 |
| Jun 18 | ESPR Esperion Therapeutics, Inc. | Koenig Sheldon L. | President and CEO, Director | Sell | $169.1K |
| Mar 16 | ESPR Esperion Therapeutics, Inc. | Koenig Sheldon L. | President and CEO, Director | Grant | $1.6M |
| Dec 18 | ESPR Esperion Therapeutics, Inc. | Koenig Sheldon L. | President and CEO, Director | Sell | $177.2K |
4 filings